SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-15-007627
Filing Date
2015-11-09
Accepted
2015-11-09 16:05:44
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015 a11515110q.htm 10-Q 972740
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 17678
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 17864
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6285
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6161
  Complete submission text file 0001214659-15-007627.txt   3578580

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS anth-20150930.xml EX-101.INS 500474
7 EXHIBIT 101.SCH anth-20150930.xsd EX-101.SCH 30141
8 EXHIBIT 101.CAL anth-20150930_cal.xml EX-101.CAL 34495
9 EXHIBIT 101.DEF anth-20150930_def.xml EX-101.DEF 101182
10 EXHIBIT 101.LAB anth-20150930_lab.xml EX-101.LAB 522379
11 EXHIBIT 101.PRE anth-20150930_pre.xml EX-101.PRE 237050
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 151215600
SIC: 2834 Pharmaceutical Preparations